Medical devices: immunology and microbiology devices: classification of in vitro human immunodeficiency virus drug resistance genotype assay. Final rule.
The Food and Drug Administration (FDA) is classifying an in vitro human immunodeficiency virus (HIV) drug resistance genotype assay into class II (special controls). The special control that will apply to this device is the guidance document entitled "Class II Special Controls Guidance Document: In Vitro HIV Drug Resistance Genotype Assay." FDA is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of this device. Elsewhere in this issue of the Federal Register, FDA is announcing the availability of the guidance document that will serve as the special control for this device.
D004279:DNA, Viral / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D018795:Device Approval; D024882:Drug Resistance, Viral / Q000235:genetics*; D004869:Equipment Safety / Q000145:classification*; D016679:Genome, Viral / Q000276:immunology*; D005838:Genotype; D006678:HIV / Q000235:genetics / Q000276:immunology*; D015658:HIV Infections / Q000145:classification* / Q000276:immunology / Q000821:virology; D006801:Humans; D066298:In Vitro Techniques; D012367:RNA, Viral / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D017422:Sequence Analysis, DNA / Q000145:classification / Q000295:instrumentation*; D014481:United States; D014486:United States Food and Drug Administration
D004279:DNA, Viral; D012367:RNA, Viral